CA 125 in Benign Gynecological Conditions

H. Meden, Meden H, A Fattahi-Meibodi, Fattahi-Meibodi A
The International journal of biological markers · 1998 · vol. 13(4) , pp. 231–237 · doi:10.1177/172460089801300411 · PMID:10228907 · W21167240
review OA: closed CC0 ⤵ 18 in-corpus citations
View on OpenAlex View on PubMed View at publisher
⚙ AI-generated summary by gemini-2.5-flash-lite, 2026-06-07 ⓘ

CA 125 levels can be elevated in various benign gynecological conditions, indicating it is a non-specific marker for peritoneal issues rather than solely ovarian malignancies.

One-sentence paraphrase of the abstract; not a substitute for reading it. No clinical advice. How this works

Abstract

The tumor marker CA 125 was initially thought to be specific for ovarian malignancies. Subsequently it was found to be raised in a variety of benign conditions, including pregnancy, pelvic inflammatory disease, tuberculosis and cirrhosis of the liver. With respect to gynecological tumors, CA 125 may be elevated in benign ovarian cysts, tubo-ovarian abscess, endometriosis, hyperstimulation syndrome, ectopic pregnancy and fibroids. These results demonstrate that CA 125 is a marker of non-specific peritoneal conditions.

My notes (saved in your browser only)

Condition tags

endometriosis

MeSH descriptors

CA-125 Antigen Genital Diseases, Female Genital Diseases, Female Ovarian Neoplasms Biomarkers, Tumor Biomarkers, Tumor CA-125 Antigen Endometriosis Endometriosis Female Genital Diseases, Female Humans Menstruation Menstruation Ovarian Neoplasms Ovarian Neoplasms Pregnancy Pregnancy, Ectopic Pregnancy, Ectopic Pregnancy, Ectopic

Citation neighborhood

Papers in the corpus that this work cites (lower rings, blue) and that cite this one (upper rings, green). Dot size scales with the paper's in-corpus citation count — bigger dot = more influential within the endo/adeno field. Click a dot to open that paper. [ expand to 2 hops ] — adds papers reached through this work's immediate citers/citees. Heavier; up to 60 extra dots.

References (48)

Cited by (18)

Source provenance

europepmc
last seen: 2026-08-23T06:15:12.370321+00:00
openalex
last seen: 2026-06-04T00:00:01.174412+00:00
pubmed
last seen: 2026-05-13T22:10:29.640636+00:00
unpaywall
last seen: 2026-08-23T06:29:45.520198+00:00
License: CC0 · commercial use OK